Latest news articles

Added 21 days ago Drug news

Mitsubishi Tanabe initiates Phase III BouNDless study of ND 0612 to treat Parkinson's disease.

Mitsubishi Tanabe Pharma America announced the initiation of the Phase III BouNDless study investigating the efficacy, safety and tolerability of...

Added 24 days ago Drug news

FDA approves Nourianz for Parkinson’s disease

The FDA has granted approval for Nourianz (istradefylline), from Kyowa Kirin Co, for use as adjunctive treatment to levodopa/carbidopa in...

Added 1 month ago Drug news

Intec Pharma reports top-line phase III trial results of Accordion Pill-Carbidopa/Levodopa inadvanced Parkinson's disease

Intec Pharma Ltd. announces top-line data from the Company's pivotal Phase III trial evaluating the safety and efficacy of the...

Search all news articles for Parkinson's disease
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

EPNS 2019 Congress Highlights

EPNS 2019 Congress Highlights

The epgonline.org team is creating daily reports from the 13th European Paediatric Neurology Society (EPNS) Congress, held in Athens, Greece from 17th to 21st September 2019, to bring you coverage of cutting-edge science and advances in clinical care across all fields of paediatric neurology. 

Migraine Knowledge Centre

Migraine Knowledge Centre

The Migraine Knowledge Centre features latest research on the prevalence and impact of migraine, the proposed neurological basis of the condition (and how this is being translated into new and exciting drug therapies), as well as current patient care strategies collated from headache organisations worldwide.

Load more

Guidelines

Parkinson’s disease in adults

This guideline covers diagnosing and managing Parkinson's disease in people aged 18 and over. It aims to improve care from the time of diagnosis, including monitoring and managing symptoms...

Added 1 year ago

Urinary incontinence in neurological disease: assessment and management

This guideline covers assessing and managing urinary incontinence in children, young people and adults with neurological disease.

Added 7 years ago

Diagnosis and pharmacological management of Parkinson’s disease

This guideline provides recommendations based on current evidence for best practice in the diagnosis and pharmacological management of Parkinson’s disease.

Added 9 years ago

Search all guidelines for Parkinson's disease
 

Journal articles

Progressive supranuclear palsy and idiopathic Parkinson's disease are associated with local reduction of in vivo brain viscoelasticity.

Objectives: To apply three-dimensional multifrequency MR-elastography (3DMRE) for the measurement of local cerebral viscoelasticity changes in patients with Parkinson's disease (PD) and progressive supranuclear palsy (PSP).

Added 3 months ago

Evaluation of Retinal Changes in Progressive Supranuclear Palsy and Parkinson Disease.

Background: Differentiating Parkinson disease (PD) from progressive supranuclear palsy (PSP) can be challenging early in the clinical course. The aim of our study was to see if specific retinal changes could serve as...

Added 3 months ago

Development of an aggregate-selective, human-derived α-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease models.

Aggregation of α-synuclein (α-syn) is neuropathologically and genetically linked to Parkinson's disease (PD). Since stereotypic cell-to-cell spreading of α-syn pathology is believed to contribute to disease progression...

Added 3 months ago

Search all journal articles for Parkinson's disease
 

Clinical trials

To Assess the Efficacy and Safety of Ceftriaxone in Patients With Mild to Moderate Parkinson's Disease Dementia

This is a randomized, double blinded, placebo-controlled Phase II study to investigate the efficacy and safety of ceftriaxone in patients with mild to moderate Parkinson's disease dementia (PDD).

Added 3 months ago

GLP1R in Parkinson's Disease (GIPD)

The trial is a single center, double-blind, placebo-controlled study. We plan to enroll 270 newly diagnosed patents with idiopathic Parkinson's disease (PD) over 2 years. The subjects that are enrolled in the study will be randomised...

Added 3 months ago

A Study of Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's Disease

The major purpose of this study is to assess the efficacy of CBD on motor symptoms of Parkinson's Disease (PD), and secondarily to study the safety and tolerability of CBD and other efficacy, particularly regarding tremor in PD.

Added 3 months ago

Search all clinical trials for Parkinson's disease
 
Dr Cornelia Meisenberg

Dr Conny Meisenberg is a medical writer at EPG Health. She joined EPG Health in 2019 following 7 years of postdoctoral research in the oncology field.

Progressive Supranuclear Palsy (PSP)

What is Progressive Supranuclear Palsy (PSP)? Review the causes, treatment and current trials for this uncommon, degenerative disorder.

CME

New Parkinson's drug, SGLT2s as monotherapy: prescribing update June 2016

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
0
Registration required
1
Subscription fee
0

Parkinson's disease: clinical review

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
1
Registration required
1
Subscription fee
0

Parkinson's disease: initial assessment and referral

Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available
1
Registration required
1
Subscription fee
90
Search all CME for Parkinson's disease